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Abstract. 
 
Matrilysin, a matrix metalloproteinase, is ex-
pressed and secreted lumenally by intact mucosal and 
glandular epithelia throughout the body, suggesting 
that its regulation and function are shared among tis-
sues. Because matrilysin is produced in Paneth cells of 
the murine small intestine, where it participates in in-
nate host defense by activation of prodefensins, we 
speculated that its expression would be inﬂuenced by 
bacterial exposure. Indeed, acute infection (10–90 min) 
of human colon, bladder, and lung carcinoma cells, pri-
mary human tracheal epithelial cells, and human tra-
 
cheal explants with type 1–piliated 
 
Escherichia coli
 
 me-
diated a marked (25–50-fold) and sustained (
 
.
 
24 h) 
induction of matrilysin production. In addition, bacte-
rial infection resulted in activation of the zymogen form 
of the enzyme, which was selectively released at the 
apical surface. Induction of matrilysin was mediated by 
a soluble, non-LPS bacterial factor and correlated with 
the release of defensin-like bacteriocidal activity. Bac-
teria did not induce matrilysin in other cell types, and 
expression of other metalloproteinases by epithelial 
cells was not affected by bacteria. Matrilysin was not 
detected in germ-free mice, but the enzyme was in-
duced after colonization with 
 
Bacteroides thetaiotaomi-
cron
 
. These ﬁndings indicate that bacterial exposure is a 
potent and physiologically relevant signal regulating 
matrilysin expression in epithelial cells.
Key words: metalloproteinase • bacteria • adhesin • 
defensin • host defense
 
Introduction
 
Although mucosal epithelia are specialized to serve set
functions among different tissues, these cells share a num-
ber of common features related to defense against infec-
tion and response to injury. For example, secreted prod-
ucts, such as antimicrobial peptides, provide the first line
of innate defense by directly killing bacteria at the mu-
cosal surface of several epithelia. In response to injury, ep-
ithelial cells initiate a programmed series of separate yet
interdependent responses, such as proliferation, migra-
tion, and matrix assembly, to rapidly restore the integrity
of damaged tissue. Furthermore, injury and infection are
not necessarily distinct events. Indeed, injury provides an
opportunity for infection, and infection can lead to injury.
Hence, some of the epithelial responses observed to be as-
sociated with either of these events may actually be a key
component of both responses. The data we present here,
along with previous observations in injured and infected
tissues, indicate that matrilysin, a matrix metalloprotein-
ase (MMP),
 
1
 
 functions during both repair and mucosal de-
fense.
Matrilysin (MMP-7) has been demonstrated in vitro to
be able to degrade or process a variety of matrix and non-
matrix proteins, including elastin, the core protein of pro-
teoglycans, fibronectin, and serpins, among others (Mur-
phy et al., 1991; Sires et al., 1993; Halpert et al., 1996).
Despite lacking the COOH-terminal hemopexin-like do-
main present in other MMPs, which is thought to restrict
substrate specificity (Birkedal-Hansen et al., 1993), matril-
ysin has the general characteristics of MMPs, such as being
secreted in a latent form (28 kD) and being inhibited by
tissue inhibitors of metalloproteinases. However, unlike
other MMPs, which are expressed or released only in re-
sponse to injury, disease, or inflammation, matrilysin is ex-
pressed by noninjured, noninflamed exocrine and mucosal
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epithelium in most, if not all, adult tissues. Specifically,
matrilysin is produced by all skin and salivary glands, air-
way ciliated cells, and by the ductal or glandular epithe-
lium of the pancreas, liver, breast, intestine, and urogenital
tissues (Wilson et al., 1992; Rodgers et al., 1994; Saarialho-
Kere et al., 1995; Wilson et al., 1995). In addition, matril-
ysin is markedly upregulated by migrating epithelium in
the injured airway (Dunsmore et al., 1998) and intestine
(Saarialho-Kere et al., 1996), suggesting that this MMP
serves a key role in the repair of epithelium. Indeed, reep-
ithelialization of the injured trachea is markedly impaired
in matrilysin-null mice (Dunsmore et al., 1998).
Several observations implicate matrilysin in innate host
defense among intact epithelia. All tissues in which matril-
ysin is constitutively expressed open to the environment
and are vulnerable to bacterial exposure, and matrilysin is
prominently upregulated in tissues with a heavy bacterial
load, such as in lungs with severe cystic fibrosis (Duns-
more et al., 1998). In the mouse small intestine, matrilysin
is expressed in Paneth cells (Wilson et al., 1995), which
are specialized defense cells that secrete defensins, lyso-
zyme, phospholipase A2, and other antimicrobial molecules
(Ouellette, 1997). Matrilysin-null mice have an impaired
ability to activate prodefensins and to kill exogenous bacte-
ria in their small intestine (Wilson et al., 1999). These ob-
servations prompted us to study if the interaction of bacte-
ria with host cells regulates the expression of matrilysin.
Bacterial adherence to epithelial host surfaces is needed
for establishment of a normal microflora, but it is also a
crucial step for infection. The molecules mediating adhe-
sion are adhesins, which are located either directly on the
cell surface (nonpilus adhesins) or on the tips of fimbriae
(pili) (Hultgren et al., 1993). FimH is a mannose-binding
adhesin that mediates the interaction of type 1–piliated
bacteria with mannose-containing glycoproteins on eu-
karyotic cell surfaces (Jones et al., 1995; Sokurenko et al.,
1997). In our studies, we used different strains of gram-
negative bacteria to assess if the interaction between bac-
teria and epithelial cells controls the expression of matril-
ysin. Our data show that bacterial exposure is a potent and
relevant process that controls matrilysin expression and
activation, suggesting a novel role for microorganisms in
the regulation of this metalloproteinase and of mucosal
defense mechanisms.
 
Materials and Methods
 
Cell and Tissue Culture
 
The human colon adenocarcinoma cell lines HT29 and WiDr, the human
lung carcinoma cell line Calu3, and the human bladder carcinoma cell line
J82 were obtained from the American Type Culture Collection. These cell
lines were maintained in RPMI 1640 medium supplemented with 10%
FBS without antibiotics. Primary human tracheal epithelial cells derived
by explant culture were supplied by Dr. Dwight Look, (Washington Uni-
versity, St. Louis, MO), and were grown in RPMI 1640/10% FBS. Normal
human skin fibroblasts (ATCC, CRL1905) were grown in DME supple-
mented with 20% FBS. The human monocytic cell line U937 was differen-
tiated by treatment with 80 nM phorbol-12-myristate 13-acetate (PMA;
Sigma Chemical Co.) and 1 
 
m
 
g/ml lipopolysaccharide (LPS; Sigma Chemi-
cal Co.) as previously described (Saarialho-Kere et al., 1993). Primary hu-
man keratinocytes were isolated from full thickness healthy skin and
grown in on collagen-coated dishes as previously described (Sudbeck et
al., 1994).
 
To study directional secretion of matrilysin, human colon epithelial
cells were plated at a high density into Transwell inserts (Costar Corp.).
After reaching confluency, the integrity of the monolayer was ascertained
by measuring the electrical resistance across the epithelial layer as de-
scribed in Dunsmore et al. (1998).
For organ culture studies, a segment of the proximal end of normal hu-
man trachea was obtained from donor lungs destined for transplants and
dissected into 1-cm
 
3
 
 pieces. Individual pieces of trachea were placed into
the wells of 6-well cluster dishes, so that the lumenal side was exposed,
and covered with 2 ml of RPMI 1640 medium supplemented with 0.5%
FBS in the absence of antibiotics.
 
Bacteria, Cytokines, and Other Reagents
 
Escherichia coli
 
 DH5
 
a
 
 was obtained from GIBCO (Life Technologies). 
 
E
 
.
 
coli
 
 ORN103 and AAEC185 are nonpathogenic laboratory strains that do
not express pili or adhesins. The recombinant strains ORN103/pSH2
and AAEC185/pSH2 express the complete type 1 pilus operon (type
1
 
1
 
/
 
fimH
 
1
 
) (Orndorff, 1987), and ORN103/pUT2002 and AAEC185/
pUT2002 (type 1
 
1
 
/
 
fimH
 
2
 
) are the respective 
 
fimH
 
2
 
 isogenic mutant
strains (Minion et al., 1986). NU14 is an 
 
E
 
.
 
 coli
 
 uropathogenic isolate that
expresses FimH-containing type 1 pili. NU14-1 is an 
 
fimH
 
2
 
 mutant in
which a chloramphenicol cassette was recombined into the 
 
fimH
 
 gene
(Langermann et al., 1997). The gut isolates, 
 
E
 
.
 
 coli
 
 G167 and EC80, are
also type 1–piliated (
 
fimH
 
1
 
) strains. We also used two
 
 E
 
.
 
 coli
 
 strains ex-
pressing the Pap operon and distinct adhesins, PagGI or PapGII (Kuehn
et al., 1992). The 
 
Salmonella typhimurium
 
 strains 14028s (mouse virulent
wild type) and ms7953s (isogenic mouse-avirulent 
 
phoP
 
 mutant) were a
gift from Dr. Fred Heffron (Oregon Health Sciences University, Portland,
OR; Fields et al., 1989). Piliated 
 
Bordetella pertussis
 
 BC23 was provided
by Dr. William Goldman (Washington University, St. Louis, MO). Re-
combinant human cytokines, interleukins, and growth factors were ob-
tained from R&D Systems, Inc. 
 
E. coli
 
 (serotypes 055:B5, 0128:B12, and
0111:B4),
 
 Klebsiella pneumoniae
 
,
 
 
 
and
 
 Pseudomonas aeruginosa
 
 (serotype
10) LPS, polymyxin B, and p-amino-phenylmercuric acetate (APMA)
were obtained from Sigma Chemical Co.
 
Infection Protocol
 
Human epithelial cells were seeded onto 6-well plates and were grown to
 
z
 
90% confluency. Expression of type 1 pili by bacteria was induced by
growing the cells in static broth at 37
 
8
 
C for 48 h and was confirmed by he-
magglutination assays as previously described (Langermann et al., 1997).
About 4 
 
3
 
 10
 
8
 
 bacteria, representing a bacterial to epithelial cell ratio of
300:1, were added in 1 ml of RPMI 1640, 0.5% FBS to each well. Bacteria
were incubated with eukaryotic cells for up to 90 min. In some experi-
ments, 100 mM 
 
D
 
-mannose, 
 
D
 
-glucose, or 
 
D
 
-maltose was included during
the 90-min infection. Epithelial monolayers were washed extensively with
PBS to remove nonadherent bacteria, and the cultures were further incu-
bated up to 48 h in RPMI 1640/0.5% FBS and 50 
 
m
 
g/ml gentamicin to kill
the remaining extracellular bacteria. Cycloheximide (10 
 
m
 
g/ml) was added
to some cultures during the postinfection incubation. Conditioned media
were collected, centrifuged at 12,000 rpm for 10 min to remove debris, and
stored at 
 
2
 
20
 
8
 
C. Each condition in each experiment was done in du-
plicate.
Infection of tracheal tissues was done with an initial inoculum of 10
 
7
 
cells per 1-cm
 
3
 
 piece of trachea added in a final volume of 2 ml of RPMI
1640 medium supplemented with 0.5% FBS. After a 90-min incubation at
37
 
8
 
C, the tissues were carefully washed with PBS before the addition of
fresh medium containing 50 
 
m
 
g/ml gentamicin. Conditioned media were
collected 48 h later as described above.
 
Immunoblotting
 
Media samples from the bacterially infected epithelial cells or tissues were
concentrated 10-fold by lyophilization. Aliquots of concentrated media
were separated by 12% SDS-PAGE and transferred to nitrocellulose
membranes (Hybond ECL; Amersham). Blots were incubated with a
1:3,000 dilution of anti-human matrilysin polyclonal antiserum in blocking
buffer for 2 h. This antiserum detects both the precursor (28 kD) and ma-
ture (19 kD) forms of human matrilysin (Busiek et al., 1992; Halpert et al.,
1996). Membranes were subsequently incubated with a 1:3,000 dilution of
a peroxide-linked donkey anti–rabbit IgG (Amersham) in blocking buffer
for 1 h, washed twice, and developed with the enhanced chemilumines-
cence system (Amersham). We also used a polyclonal antiserum raised 
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against the recombinant catalytic domain of human matrilysin (gift of Dr.
H.G. Welgus, Parke-Davis, Ann Arbor, MI), with similar results.
On our matrilysin Western blots, we often observed an additional,
higher molecular mass band migrating at 
 
z
 
70–80 kD (see Fig. 1 A). To es-
tablish the origin of this nonspecific band, we performed infection experi-
ments on live and formalin-fixed epithelial monolayers. Although the pre-
cursor and activated forms of matrilysin were produced only by live cells,
signal for the higher molecular mass band was also seen in conditioned
media from fixed cells (data not shown). This band was not seen in immu-
noprecipitates of metabolically labeled, bacterial-exposed cells but was
detected in media of cells treated with cycloheximide after infection,
which blocks matrilysin expression (data not shown; see Fig. 3). The non-
specific band was also seen in mock infections done with bacteria in the
absence of epithelial cells and was detected in bacterial broth (data not
shown). Based on these various controls, we conclude that the additional
band detected by the antimatrilysin antibodies is nonspecific and derives
from bacteria culture medium.
 
Northern Hybridization
 
About 1.5 
 
3
 
 10
 
6
 
 human colon carcinoma cells were infected with 4 
 
3
 
 10
 
8
 
bacteria for 90 min, as described above. At different times after infection,
total RNA was isolated, separated by electrophoresis, and blotted onto
nylon filters. Gel-purified cDNA probes for human matrilysin, collage-
nase-1 (MMP-1), stromelysin-1 (MMP-3), and MT1-MMP (MMP-14)
were labeled by random priming.
 
Zymography
 
Conditioned media samples were collected 48 h after infection and were
concentrated 10-fold by lyophilization. Medium samples were resolved at
4
 
8
 
C through 10% nonreducing SDS–polyacrylamide gels impregnated
with 1 mg/ml gelatin or casein. Gels were incubated overnight at 37
 
8
 
C in
50 mM Tris, pH 8.0, 5 mM CaCl
 
2
 
 and 0.5 
 
m
 
M ZnCl
 
2
 
. Gelatinolytic and
caseinolytic proteins were identified as clear bands on a dark background
after staining with 1% Coomassie blue.
 
Immunohistochemistry
 
Germ-free mice were raised as described (Bry et al., 1996). At 4 mo of
age, some germ-free mice were inoculated with 
 
B. thetaiotaomicron
 
, a
commensal bacterium of the mouse small intestine. 10 d later, age-
matched germ-free, monocontaminated ex-germ-free, and conventionally
housed mice were killed, and the jejunal segments were isolated and fro-
zen in OPTC. Frozen sections were processed for immunohistochemistry
using an HRP detection system (Vectastain ABC Elite kit; Vector Labo-
ratories, Inc.) and TrueBlue as a substrate (Kirkegaard & Perry Laborato-
ries, Inc.) as described previously (Wilson et al., 1997). Affinity-purified
anti-mouse matrilysin antibody was used at 1:5,000, and anti-CRS1C pro-
segment antibody, which reacts with several murine cryptdin-like intesti-
nal 
 
a
 
-defensins, was used at 1:500. For negative controls, sections were
processed with preimmune serum. Sections were counterstained with con-
trast red.
 
Bacterial Broth Studies
 
To obtain bacterial culture broth, 
 
E
 
.
 
 coli
 
 strains AAEC185, AAEC185/
pUT2002 (type 1
 
1
 
/
 
fimH
 
2
 
), and AAEC185/pSH2 (type 1
 
1
 
/
 
fimH
 
1
 
) were
grown overnight with shaking at 37
 
8
 
C in RPMI 1640 supplemented with
0.5% FBS. The optical density at 600 nm of the cultures was typically be-
tween 1.5 and 2.0, and in these growth conditions, piliation of the bacteria
is limited. Bacterial cultures were centrifuged for 10 min at 12,000 rpm,
cell pellets were discarded, and supernatants were sterilized by filtering
through a 0.2-
 
m
 
m filter (Gelman Sciences). For stimulation of naïve HT29
colon carcinoma cells, bacterial broth was diluted in fresh medium (RPMI
1640/0.5% FBS) and added to 5 
 
3
 
 10
 
5
 
 cells per well in 12-well plates. Con-
ditioned media from the HT29 cells were collected after 48 h and analyzed
by Western blotting as described above.
 
Bacteriocidal Assays
 
Colon epithelial cells were exposed to the ORN103/pSH2 (type 1
 
1
 
/
 
fimH
 
1
 
) strain for 90 min as described above. Bacteria were removed by
extensive washing and killed by incubation in fresh medium containing 50
 
m
 
g/ml gentamicin. After 4 h, monolayers were washed to eliminate traces
of the antibiotic, and the cells were allowed to condition fresh media for
 
48 h. Conditioned media were collected, centrifuged to remove debris,
and filtered through a 0.2-
 
m
 
m sterile filter.
For antimicrobial activity assays, 
 
E
 
.
 
 coli
 
 DH5
 
a
 
 and 
 
S
 
.
 
 typhimurium
 
bacteria were grown to the midexponential phase, washed with PBS, and
their concentration was estimated spectrophotometrically. For the liquid
growth inhibition assay, 200 
 
m
 
l of the epithelial cell conditioned media, di-
luted in water or 10 mM sodium phosphate buffer, pH 7.0, were added to
100 
 
m
 
l of bacteria at 1–5 
 
3
 
 10
 
6
 
 cells/ml. Salt concentration of conditioned
media was altered by the addition of 5 M NaCl, and the effect of the pH
was assessed using 50 mM phosphate buffer, pH 7.5, or 50 mM acetate
buffer, pH 5.5. At the start of the incubation and after 3 h of incubation at
37
 
8
 
C, the number of CFUs was determined by plating serial dilutions. All
incubations were performed at least in duplicate.
 
Results
 
Stimulation of Matrilysin by Adherent Bacteria
 
To evaluate the effect of bacterial infection on the expres-
sion of matrilysin in human epithelial cells, we incubated
WiDr human colon carcinoma cells with the recombinant
strains ORN103/pUT2002 (type 1
 
1
 
/
 
fimH
 
2
 
) and ORN103/
pSH2 (type 1
 
1
 
/
 
fim
 
1
 
) and assayed by immunoblotting
the levels of enzyme secreted into the medium. Strain
ORN103/pSH2 contains the FimH adhesin at the tip of the
bacterial pili, whereas strain ORN103/pUT2002 does not.
After 90 min, the bacteria were killed with gentamicin,
and conditioned media were collected 48 h later. Low lev-
els of promatrilysin protein (28 kD) were detected in the
medium from control cells (Fig. 1 A). The amount of
matrilysin increased slightly in the medium from cells in-
fected with the 
 
fimH
 
2
 
 mutant strain pUT2002, and a small
level of activated enzyme was detected. In contrast, infec-
tion with the adherent type 1–piliated bacteria, pSH2, led
to a marked increase in the amount of antimatrilysin mate-
rial secreted by the epithelial cells (Fig. 1 A). Three spe-
cific bands were detected with the antimatrilysin anti-
bodies. The band migrating at 
 
z
 
28 kD corresponds to
promatrilysin and, in these experiments, represents 
 
z
 
30%
of the total secreted enzyme. The band migrating at 19 kD
corresponds to activated matrilysin and represents 
 
z
 
20%
of the total secreted enzyme. The fastest migrating form, a
broad band between 10–15 kD, represents autolytically
cleaved products of matrilysin, which are predictably pro-
duced in vitro in any sample with abundant activated
matrilysin. This band does not represent the cleaved pro-
domain because our antibodies do not recognize this re-
gion of the protein. Totaling the densitometric values
for these three bands indicated that infection with the
ORN103/pSH2 strain mediated about a 50-fold increase in
the amount of secreted matrilysin compared with the low
levels released by noninfected cells (Fig. 1 A).
Because the type 1 pili harboring the adhesin FimH me-
diate the attachment of uropathogenic 
 
E
 
.
 
 coli
 
 to the mu-
cosal surface of the bladder (Langermann et al., 1997;
Mulvey et al., 1998), we assessed if these bacteria affected
matrilysin expression by human bladder cells. No matril-
ysin was detected in the conditioned media from nonin-
fected J82 bladder carcinoma cells (Fig. 1 B). A slight in-
duction and processing of matrilysin was observed in cells
exposed to the parental strain ORN103 or to the FimH-
deficient strain ORN103/pUT2002 (type 1
 
1
 
/
 
fimH
 
2
 
) (Fig. 1
B). However, infection with the ORN103/pSH2 (type 1
 
1
 
/
 
fimH
 
1
 
) strain potently induced the secretion and activa- 
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tion of matrilysin (Fig. 1 B). Furthermore, the same quan-
titative stimulation and pattern of matrilysin release and
activation were seen with a variety of other human epithe-
lial cell lines tested, including HT29 colon carcinoma cells,
Calu3 lung carcinoma cells, as well as with primary human
tracheal epithelial cells from normal lung (see Fig. 7 B).
To further characterize the bands detected by the anti-
matrilysin antiserum, we induced the autolytic activation
of prometalloproteinases present in the conditioned media
from colon epithelial cells. In the conditioned media from
cells stimulated with TNF
 
a
 
 or exposed to bacteria, APMA
treatment led to a reduction in the density of the 28-kD
promatrilysin band and a predicted shift to the activated
form of 19 kD (Fig. 1 C). Furthermore, matrilysin in the
conditioned media samples showed caseinolytic activity in
substrate zymograms, and this activity was inhibited by
EDTA (data not shown). In contrast, the density of the
nonspecific band (NS) was not altered by APMA treat-
ment (Fig. 1 C), suggesting that this band does not repre-
sent promatrilysin complexed with other products.
 
Vectorial Secretion of Matrilysin
 
Typically, bacteria initially interact with epithelial tissues
at the apical surface. To examine the effect of bacterial
challenge on the directional secretion of matrilysin, we
plated WiDr colon epithelial cells in Transwell inserts and
bacteria were added to the upper chamber. The integrity
of the epithelial monolayer was verified by measuring the
transepithelial electrical resistance, which was unaffected
by bacterial infection. Promatrilysin, which was secreted
by control cells, was released in nearly equal proportions
into the basal and apical chambers (Fig. 1 D). In response
to bacterial exposure, matrilysin production and activation
were markedly increased, and all of the stimulated zy-
mogen and activated enzyme were released into the upper
compartment (Fig. 1 D). These data indicate that in addi-
tion to potently augmented production, bacteria regulate
the vectorial secretion of matrilysin towards the apical sur-
face.
 
mRNA Levels
 
We also examined if adherent bacteria stimulated matril-
ysin gene expression. HT-29 colon carcinoma cells were
infected with NU14, a FimH-expressing, type 1–piliated
uropathogenic isolate. At 2 h after a 90-min infection,
matrilysin mRNA levels were stimulated slightly above
control levels, but by 5 h after infection, matrilysin mRNA
levels had increased 
 
z
 
10-fold and remained elevated at
24 h (Fig. 1 E). The sustained elevated levels of matrilysin
mRNA allowed for the increase in total secreted enzyme
accumulated over a 48-h postinfection period.
 
Effect of Other Mediators
 
We assessed if other host-derived mediators, known either
to stimulate matrilysin expression or to be influenced by
bacterial exposure, affected matrilysin production by hu-
man epithelial cells. TNF
 
a
 
 mediated only a 5–7-fold in-
crease in the amount of matrilysin secreted by epithelial
cells and only the 28-kD zymogen form of matrilysin was
seen (Fig. 1 A; Table I). Most of the factors we used, such
as HGF/SF and IL-8, did not influence matrilysin produc-
tion, and others, such as IL-6, IL-1
 
b
 
, and phorbol ester,
stimulated enzyme production modestly. Of note, bacte-
rial LPS did not modulate matrilysin expression by epithe-
lial cells (Table I), although this compound does stimulate
enzyme expression in monocytes (Busiek et al., 1992; see
Fig. 4 C).
 
Time and Dose Response
 
The accumulation of matrilysin in the conditioned media
of infected HT29 cells was dependent on the number of
bacteria added to the culture (Fig. 2 A). Demonstrating
that epithelial cells are extremely sensitive to bacterial in-
fection, a 5- to 10-fold increase in secreted matrilysin was
detected even when the ratio of bacterial-to-epithelial
cells was 
 
,
 
1 (Fig. 2 A). We also assessed the effect of in-
fection time on matrilysin secretion. Similar to that seen
with a 90-min infection (Fig. 1, A and B), matrilysin secre-
tion and activation were markedly stimulated by a 60-min
exposure to adherent bacteria (Fig. 2 B), although shorter
incubations also upregulated matrilysin secretion (Fig. 2
Figure 1. FimH-dependent induction and activation of matrilysin
in epithelial cells. (A) WiDr human colon carcinoma cells were
infected for 90 min with E. coli strains ORN103/pUT2002 (type
11/fimH2) and ORN103/pSH2 (type 11/fimH1) at a ratio of 300:1
bacteria/epithelial cells. Cultures were washed extensively and
re-fed with medium containing 50 mg/ml gentamicin. Some cul-
tures were treated for 48 h with 50 ng/ml of human recombinant
TNFa. Conditioned media were collected 48 h after infection and
analyzed by Western blotting for matrilysin protein. The 28-kD
proform of matrilysin (Pro), the 19-kD activated form of matril-
ysin (Mat), and autolytic fragments (broad migrating faster be-
low activated matrilysin) were seen in pSH2-infected cells. A
nonspecific (NS) band is seen at z70 kD. Numbers on the left
side of the autoradiogram indicate the migration of molecular
mass standards. Samples from two separate cultures were ana-
lyzed for each group. (B) J82 human bladder carcinoma cells
were infected for 90 min with the parental E. coli strain ORN103
and the recombinant strains ORN103/pUT2002 and ORN103/
pSH2. Conditioned media were collected 48 h later, and the ex-
pression of matrilysin was analyzed by Western blotting. (C) Ali-
quots of conditioned media from TNFa-stimulated (TNF) or
ORN103/pSH2-infected (Bact) colon epithelial cells were incu-
bated at 378C for 1 h in the presence or absence of 1 mM APMA,
and the products were analyzed by Western blotting. (D) WiDr
colon cells were grown on Transwell inserts, and some cultures
were infected with ORN103/pSH2. Conditioned media was col-
lected after 48 h from the apical and basal compartments and an-
alyzed by Western blotting. (E) HT29 colon cells were infected
for 90 min with E. coli NU14 (300 bacteria per epithelial cell).
Total RNA was isolated at the indicated times after the infection.
Matrilysin mRNA was detected by Northern hybridization.López-Boado et al. Regulation of Matrilysin by Bacteria 1309
B). With infections longer than 90 min, extensive cell
death was seen (data not shown).
Mannose Inhibition
Adhesion of FimH-containing type 1 pili to epithelial cells
can be inhibited by D-mannose and its derivatives (Firon et
al., 1987). To investigate if the induction of matrilysin ex-
pression triggered by FimH-expressing bacteria was sensi-
tive to mannose, we infected WiDr cells with the recom-
binant strains ORN103/pUT2002 (type 11/fimH2) and
ORN103/pSH2 (type 11/fimH1) in the presence or ab-
sence of 100 mM mannose. Addition of mannose effec-
tively blocked the FimH-mediated increase in matrilysin
release, but had no effect on the smaller stimulation seen
in cells infected with the FimH-deficient strain (Fig. 3).
Other sugars, such as glucose or maltose, did not affect the
bacterial-mediated stimulation of matrilysin (data not
shown). In addition, as demonstrated by the complete lack
of detectable protein in the presence of cycloheximide, the
bacterial-mediated stimulation of matrilysin required new
protein synthesis (Fig. 3).
Inductive Factor Is Released by Bacteria
Because expression of matrilysin was induced by bacteria
even in the presence of mannose, it is likely that a bacterial
soluble factor affects enzyme production. To investigate
this possibility, we grew strains of E. coli bacteria to obtain
sterile liquid broth filtrates, which were diluted in fresh
cell culture medium, and added to HT29 colon carcinoma
cells. Bacterial broth from the strain AAEC185/pSH2
(type 11/fimH1) induced matrilysin expression by epi-
thelial cells in a dose-dependent fashion (Fig. 4 A). A
7–10-fold accumulation of promatrilysin was observed
with a 1:5 dilution of the liquid broth, although no pro-
cessing of matrilysin to the active form was observed. Sim-
ilar results were obtained with bacterial broths from E.
coli AAEC185 and AAEC185/pUT2002 (type 11/fimH2)
(data not shown).
Although different preparations of commercial LPS,
which are essentially devoid of protein, had no effect on
matrilysin expression by HT29 colon cells (Table I), we
could not rule out the possibility that the LPS-containing
complexes naturally released by the bacteria may be par-
tially responsible for the upregulation of matrilysin. In this
respect, the addition of polymyxin B, an antibiotic which
specifically binds LPS and has anti-endotoxin properties,
did not block the induction of matrilysin in response to
bacterial broth filtrates (Fig. 4 B). These findings suggest
that the inductive factor is unrelated to LPS. In addition,
cycloheximide totally abrogated accumulation of matril-
ysin, indicating that de novo protein synthesis is required
(Fig. 4 B). Predictably, polymyxin B blocked LPS-induced
accumulation of matrilysin in U937 human monocytic-like
Table I. Comparison of the Relative Induction and Activation 
of Matrilysin by Bacteria, Cytokines, and Other Stimuli
Condition Concentration Fold induction Matrilysin activation
ng/ml
No stimulus 2
Adherent bacteria 50–75 1
Nonadherent bacteria 5–10 6
IL-1b 10–25 12 2
IL-6 25–50 8 2
TNFa 25–50 7 2
EGF 100 3 2
Phorbol ester 10–50 3 2
LPS 1,000 ne 2
IFN-g 50–100 ne 2
IL-4 20–50 ne 2
HSF/SF 30–60 ne 2
GM-CSF 50 ne 2
IL-8 100 ne 2
MCP-1 50–100 ne 2
TGF-b1 100 ne 2
HT29 human colon epithelial cells were plated on 6-well plates and infected with bac-
teria (300 bacterial/cell) or treated with the indicated concentrations of cytokines and
other stimuli. Western blotting was performed on conditioned media collected 48 h af-
ter infection or 48 h after addition of the other stimuli. Autoradiograms were analyzed
by densitometry, and the results are expressed relative to the values of control cells
(ne, no effect). (1) 50% or more activated matrilysin; (6) ,50% activated matrilysin;
and (2) no activated matrilysin.
Figure 2. Dose dependence and time-course analysis of bacteri-
ally induced upregulation of matrilysin. (A) HT29 human colon
epithelial cells were infected for 90 min with E. coli strain
ORN103/pSH2 (type 11/fimH1) at the indicated bacterial/epithe-
lial cell ratio. (B) HT29 cells were infected with the recombinant
strain ORN103/pSH2, at a ratio of 300 bacteria per epithelial cell,
for different periods of time, from 5 to 60 min. Conditioned me-
dium samples were collected at 48 h after infection and analyzed
by Western blotting. (Pro) 28-kD proform of matrilysin; and
(Mat) 19-kD activated matrilysin.
Figure 3. Mannose inhibits FimH-mediated induction and activa-
tion of matrilysin. WiDr human colon epithelial cells were in-
fected for 90 min with the recombinant strains ORN103/
pUT2002 (type 11/fimH2) and ORN103/pSH2 (type 11/fimH1)
at a ratio of 300 bacteria per epithelial cell, in the presence or ab-
sence of 100 mM mannose or 10 mg/ml cycloheximide (CHX).
Conditioned media were collected after a 48-h incubation and
analyzed by Western blotting. (Pro) 28-kD proform of matrilysin;
and (Mat) 19-kD activated matrilysin.The Journal of Cell Biology, Volume 148, 2000 1310
cells (Fig. 4 C). However, matrilysin was not induced in ei-
ther basal or differentiated U937 cells in response to bac-
terial broth filtrates (Fig. 4 C; data not shown). Together,
these results indicate that different bacterial factors and
host cell pathways regulate matrilysin expression in epi-
thelial cells and monocytic/macrophages.
Other Bacteria
We assessed if other bacteria induce matrilysin expression.
WiDr colon carcinoma cells were infected with clinical iso-
lates of uropathogenic E. coli grown under conditions that
favor expression of type 1 pili (Langermann et al., 1997).
Infection with the NU14 isolate strongly induced the ex-
pression and processing of matrilysin, whereas the isogenic
FimH-deficient strain, NU14-1, had a much reduced effect
(Fig. 5 A). Demonstrating further that FimH-expressing
strains induce matrilysin expression in epithelial cells, in-
fection with the isolates G167 and EC80, both of which ex-
press FimH-containing pili, also stimulated matrilysin re-
lease and activation (Fig. 5 A).
To assess if piliated bacteria containing other adhesins
induce matrilysin expression, we infected colon cells with
the E. coli expressing type P pili, which contains PapG ad-
hesins (Kuehn et al., 1992). Infection with the bacteria ex-
pressing the PapGI adhesin had no effect on matrilysin
production, whereas bacteria expressing the PapGII ad-
hesin stimulated matrilysin release similar to FimH bacte-
ria (Fig. 5 B). Avirulent (ms7953s) and virulent (14028s)
strains of S. typhimurium, which can adhere quite effi-
ciently to human colon cells (Finlay and Falkow, 1990),
also stimulated matrilysin expression and activation in
HT-29 human colon carcinoma cells (Fig. 5 C), although at
a lower level than seen with some of the E. coli strains. In-
fection of colon epithelial cells with B. pertussis BC23 at
two different multiplicities of infection did not affect
matrilysin expression (Fig. 5 D).
Cell Specificity
Matrilysin is predominantly expressed by mucosal epithe-
lial cells in normal and injured tissues (Saarialho-Kere et
al., 1995; Wilson et al., 1995; Dunsmore et al., 1998), as
well as by tumor cells of epithelial origin (McDonnell et
al., 1991; Newell et al., 1994; Saarialho-Kere et al., 1996;
Wilson et al., 1997). To investigate if acute bacterial expo-
sure stimulates matrilysin expression in other cell types,
we infected normal human skin fibroblasts, basal and dif-
ferentiated U937 monocytic-like cells, and primary human
keratinocytes with type 1–piliated E. coli strains. Each of
these cell types produces a variety of MMPs, however,
matrilysin was not detected in any of these cells after
infection with parental or type 1–piliated bacteria (Fig. 6,
A–C). In contrast, a predictably strong matrilysin response
was observed with WiDr colon epithelial cells exposed to
FimH-expressing E coli.
Furthermore, bacteria did not influence the production
of other MMPs by epithelial cells. The expression of colla-
genase-1 (MMP-1) by primary keratinocytes was not al-
tered by bacterial exposure (Fig. 6 D). As determined by
substrate zymography, gelatinase-B (MMP-9) was not re-
leased by HT-29 cells (Fig. 6 E). In contrast, acute bacte-
rial infection stimulated slightly (about fivefold) the re-
lease of gelatinase-B by U937 cells, but still at levels that
were markedly less than those stimulated by PMA/LPS
treatment (Fig. 6 E). Production of gelatinase-A (MMP-2)
by U937 or HT-29 cells was not affected by bacteria (Fig. 6
E). Similarly, bacterial infection did not induce expression
Figure 4. Inductive activity in bacterial conditioned medium. (A)
HT29 human colon cells were treated with different dilutions of
bacterial broth from the strain AAEC185/pSH2 (type 11/fimH1)
for 48 h, and matrilysin was assayed by Western blotting. (Cntl)
Unstimulated cells; and (Pro) 28-kD promatrilysin. (B) HT29 cell
cultures were incubated in duplicate with a 1:10 dilution of bacte-
rial broth from the strain AAEC185/pSH2, in the presence or ab-
sence of 103 U/ml polymyxin B (Pmx B) and 10 mg/ml cyclohex-
imide (CHX). (C) U937 human monocytic cells were incubated
in the presence of 1 mg/ml E. coli LPS, and a 1:5 dilution of bacte-
rial broth, in the presence or absence of 103 U/ml polymyxin B.
MMP-7 denotes an aliquot of conditioned media from HT29 cells
stimulated with bacterial broth.
Figure 5. Induction of matrilysin by adherent clinical isolates of
E. coli and other bacteria. (A) WiDr human colon epithelial cells
were infected for 60 min at a ratio of 300 bacteria per epithelial
cell. The bacteria used were the type 1–piliated strains NU14, the
isogenic FimH-deficient strain NU14-1, and the isolates G167
and EC80. (B) HT29 cells were infected with E. coli expressing
type P pili and either the papGI or papGII adhesin. (C) HT29
cells were infected with S. typhimurium strains 14028s and
ms7953s. (D) HT29 cells were infected with B. pertussis BC23 at
two different ratios of bacteria to epithelial cell: 50:1 (low) and
500:1 (high). Western blotting was done with media collected
48 h after infection.López-Boado et al. Regulation of Matrilysin by Bacteria 1311
of stromelysin-1 (data not shown) or collagenase-1 (MMP-1)
or stimulate the low levels of MT1-MMP mRNA in colon
carcinoma cells (Fig. 6 F).
Ex Vivo and In Vivo Stimulation
To assess if bacteria regulate matrilysin expression in a
complex tissue environment, we infected freshly isolated
pieces of normal adult human trachea. Tracheal explants
were exposed to type 1–piliated bacteria for 90 min, and
the expression of matrilysin was determined by immuno-
blotting 24 h later. A low level of promatrilysin was de-
tected in the medium from noninfected explants (Fig. 7
A). Exposure to fimH1 bacteria (NU14) mediated a signif-
icant increase in matrilysin release and activation, whereas
the  fimH2  mutant bacteria caused a noticeable but re-
duced stimulation (Fig. 7 A). Similarly, infection with pili-
ated E. coli strains induced matrilysin expression in pri-
mary human tracheal epithelial cells (Fig. 7 B). Matrilysin
was not produced by control tracheal epithelial cells (Fig.
7 B), even though these cells produce the enzyme in intact,
normal tissue (Fig. 7 A; Dunsmore et al., 1998). Because
the cells were isolated and grown under sterile conditions,
the absence of bacteria may have eliminated the agent that
mediates gene expression in vivo.
In vivo, matrilysin is produced in many epithelia, possi-
bly because of prior or continued contact with pathogenic
or commensal bacteria. In the postnatal mouse, matrilysin
is prominently expressed by the epithelial Paneth cells lo-
cated at the base of the small intestinal crypts (Fig. 8; Wil-
son et al., 1995). To assess if the expression of matrilysin
by Paneth cells is regulated by bacterial exposure, we com-
pared the production of this MMP in the small intestine of
germ-free and ex-germ-free mice belonging to the NMRI
inbred strain (Bry et al., 1996). Matrilysin protein was not
detected in the Paneth cells of germ-free mice lacking an
intestinal microflora (Fig. 8), but it was induced within 10 d
after monocontamination with the commensal species B.
thetaiotaomicron (Fig. 8). In contrast, expression of the
a-defensin peptide proCRS1C, a marker of Paneth cell
differentiation (Ouellette et al., 1994), was not affected
(Fig. 8). These in vivo findings suggest that bacterial expo-
sure is a key, physiologically relevant regulator of matril-
ysin expression.
Antimicrobial Activity
Human epithelial cells produce a variety of antimicrobial
molecules, including defensins and cathelicidins (Zanetti
et al., 1995; Stolzenberg et al., 1997), and we have recently
reported that matrilysin is needed to activate murine intes-
tinal  a-defensins (Wilson et al., 1999). On its own, ma-
trilysin has no bacteriostatic or bacteriocidal properties
(Wilson et al., 1999). We assessed if bacterial-mediated in-
duction and activation of matrilysin correlated with the
generation of defensin-like bacteriocidal activity. Media
collected from control and infected HT29 human colon
cells were incubated with E. coli DH5a and with two
strains of Salmonella typhimurium, ms7953s and 14028s.
Conditioned media from infected HT29 cells caused a
marked decrease (z10,000-fold at a 1:5 dilution) in the
number of viable bacteria of all three strains (Fig. 9 A,
filled symbols), whereas conditioned media from nonin-
fected epithelial cells had no effect on bacterial survival
(Fig. 9 A, open symbols). Bacteriocidal activity was time-
Figure 6. Cell type specificity of bacterial induction of matrilysin
and lack of induction of other MMPs in epithelial cells. Human
skin fibroblasts (A), U937 human monocytic-like cells (B), and
primary human keratinocytes (C) were infected with the parental
strain ORN103 and the type 1–piliated strains ORN103/pUT2002
(type 11/fimH2) and ORN103/pSH2 (type 11/fimH1). Western
blotting for matrilysin (A, B, and C; MMP-7) and collagenase-1
(MMP-1; D) was performed on conditioned media collected 48 h
after infection. WiDr human colon epithelial cells infected with
ORN103/pSH2 were included as positive controls (A). (Cntl)
Uninfected cells; and (Std) purified human collagenase-1. (E)
Gelatin zymography was performed on serum-free conditioned
media samples from infected U937 and HT29 cells. Zones of sub-
strate clearing correspond to the activities of gelatinase-A
(MMP-2) and gelatinase-B (MMP-9). A strong induction of ge-
latinase-B was observed in U937 cells treated for 24 h with 1 mg/
ml E. coli LPS and 80 nM PMA. No gelatinolytic activity was
seen in gels incubated in the presence of 50 mM EDTA (data not
shown). (F) Northern blot analysis for collagenase-1 (MMP-1)
and MT1-MMP mRNAs was performed using total RNA iso-
lated from HT29 cells at 6 h after infection. RNA from U937 cells
stimulated with LPS and PMA was used as a positive control for
the expression of these MMPs. Ethidium bromide staining veri-
fied equal loading among lanes before and after transfer.
Figure 7. Ex vivo infection
of human tracheal explants
and infection of human tra-
cheal epithelial cells. (A)
Pieces (1 cm3) of freshly iso-
lated normal adult human
trachea were infected with
the E. coli clinical isolates
NU14 (fimH1) and NU14-1
(fimH2) for 90 min, washed
extensively to eliminate nonadherent bacteria, and incubated for
24 h in fresh media containing 50 mg/ml gentamicin. Released
matrilysin was detected by Western analysis. (B) Human tracheal
primary epithelial cells were infected with the type 1–piliated
recombinant strains ORN103/pSH2 (fimH1) and ORN103/
pUT2002 (fimH2) for 90 min, and allowed to condition fresh me-
dia for 48 h. Matrilysin secretion was assessed by immunoblot-
ting.The Journal of Cell Biology, Volume 148, 2000 1312
and dose-dependent, and essentially the same results were
obtained using logarithmic or stationary growth phase
bacteria (Fig. 9 A and data not shown).
Antimicrobial activity decreased as the NaCl concentra-
tion was increased, and was essentially abolished at NaCl
concentrations over 200 mM (Fig. 9 B). In addition, bacte-
riocidal activity was reduced at low pH, but was present at
physiologic pH (Fig. 9 C). In contrast, the temperature did
not markedly affect the bacteriocidal activity. Preincuba-
tion of conditioned media from bacterially infected cells at
708C for 30 min did not result in a significant loss of the an-
timicrobial activity and preincubating at 958C blocked
,50% of the activity (Fig. 9 D). The biochemical proper-
ties of the antimicrobial activity in conditioned medium,
namely sensitivity to salt and pH and resistance to temper-
ature, are characteristic features of activated defensin pep-
tides (Bals et al., 1998a,b; Porter et al., 1997).
Discussion
Our data demonstrate that expression of matrilysin, a
member of the MMP family, is strongly induced in human
and murine mucosal epithelial tissues, cells, and cell lines
by bacterial exposure. This induction was remarkably po-
tent and sensitive, requiring relatively short exposure and
,10 bacteria per epithelial cell in the initial inoculum (Fig.
2). Large amounts of matrilysin protein, in both its zy-
mogen and activated forms, were released from infected
cells, and strictly toward the apical surface (Fig. 1 D).
Based on mRNA levels, matrilysin expression increased as
early as 2 h after infection, and remained elevated at 24 h
after infection (Fig. 1 E). In addition, bacteria-mediated
stimulation of matrilysin was specific to mucosal epithelial
cells, and expression of no other metalloproteinases exam-
ined was influenced by bacterial exposure (Fig. 6). Along
with several other studies on the production of cytokines
and chemokines and on changes in cytoplasmic signaling
and cytoarchitecture (Finlay and Cossart, 1997), our find-
ings indicate that epithelial cells are well tuned to respond
to bacterial infection.
In this work, we used E. coli bacteria producing type 1
pili and containing the FimH adhesin as a paradigm of
bacterial adherence to host cells and tissues. The binding
of molecules such as adhesins to specific receptors on host
target cells constitutes a critical step in the establishment
of bacterial infection and virulence (Hultgren et al., 1993).
Many pathogenic bacteria invade cells in tissue culture, as
shown by the ability of the internalized bacteria to survive
the antibiotic gentamicin (Miller, 1995). However, we ob-
served only negligible rates of bacterial invasion in colon
epithelial cells under our experimental conditions, even
for the more adherent E. coli strains. In addition, pretreat-
ment of epithelial cells with cytochalasin D, which blocks
bacterial invasion by disrupting the host cell actin cyto-
skeleton, had no effect on the induction of matrilysin (data
not shown). Thus, bacterial invasion clearly was not re-
quired for induction of matrilysin expression.
Bacteria could initiate matrilysin expression by adhe-
sion to a host receptor, by a soluble factor acting on host
cells, or by a combination of these two mechanisms. Sev-
eral observations indicate that a bacterially derived solu-
ble factor may be the predominant means by which ma-
trilysin is regulated. First, although mannose markedly
attenuated induction by fimH1 E. coli, this sugar did not
affect the stimulation of matrilysin mediated by the non-
Figure 8. Bacterial-medi-
ated induction of matrilysin
in mouse small intestine.
Immunostaining for mouse
matrilysin and proCRS1C
was done on frozen sections
of the small intestine pre-
pared from conventionally
housed, germ-free, and ex-
germ-free NMRI mice. Posi-
tive staining for matrilysin
(blue) was seen in the Paneth
cells located at the base of
the intestinal crypts in mice
with a normal intestinal mi-
croflora but was not detected
in the small intestine of
germ-free mice. Paneth cell
expression of matrilysin was
induced within 10 d after
contamination with B. the-
taiotaomicron. No changes in
the staining pattern or inten-
sity of procryptdin-related
sequences (proCRS1C), a
marker of Paneth cell differ-
entiation, were seen in any
samples studied.López-Boado et al. Regulation of Matrilysin by Bacteria 1313
adherent strains (Fig. 3). Similarly, NU14-1, the fimH2
mutant of clinical isolate NU14, stimulated matrilysin ex-
pression but not as greatly as did the adherent fimH1
strain (Fig. 5). Second, matrilysin was not detected in in-
testinal Paneth cells of germ-free mice, but it was induced
after inoculation with B. thetaiotaomicron (Fig. 8). This
normal inhabitant of the murine and human distal intes-
tine does not appear to colonize the crypts of Lieberkühn
(Garabedian et al., 1997; Falk et al., 1998). These in vivo
results suggest that a factor or factors released by Bacte-
roides into the intestinal lumen influenced matrilysin gene
expression in Paneth cells at the bottom of the crypts.
Third, and most compelling, bacterially conditioned broth
induced expression of matrilysin (Fig. 4). Thus, our results
indicate strongly that a soluble factor or factors released
by bacteria regulate matrilysin expression. Similarly, sev-
eral bacterial factors, or modulins, stimulate host cell cy-
tokine production and other effects (Henderson et al.,
1996; Wilson et al., 1998). Although the nature of this pu-
tative modulin(s) is currently unknown, it is probably un-
related to bacterial lipopolysaccharide. After all, LPS
from several different strains did not affect matrilysin ex-
pression, and polymyxin B did not block induction by con-
ditioned medium (Table I and Fig. 4).
Although our data argue in favor of a soluble factor
(modulin) controlling matrilysin expression, they do not
diminish the importance of bacterial adhesion. Clearly, the
most potent stimulation and induction of matrilysin were
obtained with epithelial cells exposed to adherent bacteria
(Figs. 1, 3, and 5). Bacterial adhesion could provide a
mechanism to effectively increase the concentration of a
soluble factor at the host cell surface. Furthermore, be-
cause adhesion mediates new gene expression in bacteria
(Falkow, 1997), additional modulins could be produced
once a bacterium contacts a host cell. Together, our data
suggest that both bacterial adhesion and soluble factors
are at play in the regulation of matrilysin, and synergy be-
tween two different mechanisms could be responsible for
the higher levels of induction and activation observed in
cells exposed to adherent bacteria.
As with all metalloproteinases, matrilysin is produced as
an inactive zymogen, and bacterial adhesion may also be
involved in regulating the activation of promatrilysin. In
our experiments, we detected an abundance of activated
(19 kD) matrilysin in the medium of cells exposed to ad-
herent bacteria (Figs. 1, 3, and 5). Typically, but not al-
ways, only promatrilysin (28 kD) was released by cells ex-
posed to nonadherent mutant strains (Figs. 1 and 5 A) or
to bacterial conditioned culture broth (Fig. 4). Because
bacteria were removed or killed and the medium was
changed before the start of the 48-h conditioning period,
cleavage of promatrilysin was not mediated by a bacterial
product. Still, activation of an epithelial cleavage mecha-
nism may require bacterial adhesion or, at least, exposure.
For example, the presence of activated matrilysin released
from human tracheal explants exposed to either fimH2 or
fimH1 bacteria (Fig. 7) supports this idea.
We recently reported that nearly equal amounts of both
pro and active matrilysin are stored in Paneth cells gran-
ules in intact small intestine (Wilson et al., 1999). In addi-
tion, about half of the Paneth cell granule defensins, which
are substrates for matrilysin, were also stored in a cleaved,
activated state (Wilson et al., 1999). These findings pro-
vide in vivo evidence indicating that proteolytic processing
of matrilysin is required for catalytic activity. Thus, the ac-
tivation we report here may represent a physiologically
relevant process. However, promatrilysin has a propensity
to autoactivate and degrade itself, in a concentration-depen-
dent manner. Thus, the presence of activated and de-
graded matrilysin seen in our immunoblots could be prod-
ucts of autolysis expedited by the high levels of enzyme
released in response to adherent bacteria.
The expression of matrilysin in noninjured, normal epi-
thelium suggests that this enzyme serves a common ho-
meostatic function among epithelia. In intact epithelium
and in polarized monolayers, matrilysin is preferentially
secreted to the apical surface (Wilson et al., 1997; Duns-
more et al., 1998). As we show here (Fig. 1 D), bacterial-
stimulated matrilysin is released to the apical surface. In
contrast, matrilysin is released toward the basal compart-
ment by epithelium migrating over injured airway and by
phorbol ester–stimulated pneumocytes (Dunsmore et al.,
1998). These observations indicate that the vectorial secre-
tion of matrilysin is regulated in response to different
Figure 9. Characterization of bacteriocidal activity in the epithe-
lial cell conditioned media. (A) E. coli DH5a and S. typhimurium
strains 14028s and ms7953s were incubated for 3 h at 378C in the
presence of different dilutions of conditioned medium from
HT29 human colon epithelial cells, which were previously in-
fected with the ORN103/pSH2 (type 11/fimH1) strain (solid sym-
bols), and from uninfected HT29 cells (open symbols). The num-
ber of colony forming units (CFU) was determined by plating
serial dilutions of the cultures. The input number of bacteria was
2 3 107 (DH5a), 2 3 106 (14028s), and 106 (ms7953s) CFU/ml, re-
spectively. (B) DH5a bacteria (2 3 106 CFU/ml) were incubated
for 3 h at 378C in a 1:5 dilution of conditioned medium from bac-
terially infected or control HT29 cells containing increasing con-
centrations of NaCl. Serial dilutions were plated, and the number
of colonies was determined after an overnight incubation at 378C.
(C) S. typhimurium 14028s (107 CFU/ml) and ms7953s (2.6 3 107
CFU/ml) cells were incubated in the presence of a 1:5 dilution of
conditioned medium from bacterially infected HT29 cells at pH
7.5 (50 mM phosphate buffer) or pH 5.5 (50 mM acetate buffer).
(D) S. typhimurium 14028s and ms7953s cells were incubated
with a 1:5 dilution of HT29 conditioned medium that was prein-
cubated at 708C for 30 min or at 958C for 5 min.The Journal of Cell Biology, Volume 148, 2000 1314
events and stimuli, and suggest that the proteinase may
serve different roles at the lumenal and basal surfaces.
Secretory epithelia, such as upper airway and sweat and
salivary glands, that express matrilysin open to the outside
environment and, hence, would eventually be exposed
to microorganisms. Thus, the widespread expression of
matrilysin in glandular exocrine epithelium may have been
initially induced and subsequently sustained by continual,
low level bacterial exposure. Consistent with this idea,
matrilysin is seen in adult tissues, but is not detected in de-
veloped human sweat glands in utero (Karelina et al.,
1994) or in fetal mouse tissues (Wilson et al., 1995). Our in
vivo observations that matrilysin protein is not produced
in adult germ-free mice but is detected in mice with a con-
ventional microflora (Fig. 8) directly support the concept
that bacterial exposure regulates the expression of this
proteinase. As we show here (Fig. 9), both matrilysin and
defensin-like activity, which are functionally related (see
below), are stimulated in response to challenge by patho-
genic bacteria, suggesting common regulatory control of
mucosal defense components in differentiated cells.
The levels of matrilysin produced after bacterial infec-
tion were considerably higher than those detected after
treatment with TNFa, IL-1b, and other cytokines or
chemokines that stimulate matrilysin in epithelial cells
(Klein et al., 1997). Many of these agents, such as TNFa
and several interleukins, which stimulated matrilysin ex-
pression, are themselves upregulated in epithelial cells in
response to bacterial infection (Jung et al., 1995). A pri-
mary function of these factors in response to challenge by
pathogenic bacteria is thought to be their ability to sig-
nal leukocyte recruitment to the site of infection. In con-
trast, other host proteins, such as antimicrobial peptides,
which are upregulated or released in response to infection,
function to directly counter bacterial exposure. Thus, the
presence of commensal bacteria or transient, low level ex-
posure to pathogenic bacteria may induce a noninflamma-
tory response, possibly reflected by the constitutive ex-
pression of matrilysin in healthy, noninflamed tissues. In
contrast, infection and colonization with pathogenic bacte-
ria mediates expression of proinflammatory cytokines and
chemokines, and stimulation or upregulation of matrilysin
may reflect an enhanced capacity for mucosal defense.
In accordance with the suggested role of epithelial cells
as sensors for microbial infection (Kagnoff and Eckmann,
1997), stimulation of matrilysin expression may be part of
a more general activation response to bacteria. It is tempt-
ing to speculate that the expression of matrilysin in epithe-
lial cells, along with an ever increasing display of epithelial
defense molecules, may play a direct role in the first line of
defense against infectious microorganisms. In contrast,
other MMPs, such as collagenases and stromelysin-1,
whose expression can be stimulated by inflammation (Ma-
trisian, 1992) and specific products of pathogenic bacteria
(DeCarlo et al., 1998), may participate in localized tissue
destruction, such as in periodontal disease (Birkedal-
Hansen, 1993). A growing body of evidence suggests that
most epithelial cells can produce molecules with antimi-
crobial properties (McCray and Bentley, 1997; Stolzen-
berg et al., 1997; Bals et al., 1998c; Krisanaprakornkit et
al., 1998), many of which, like matrilysin, are upregulated
by bacterial infection (Tarver et al., 1998). Indeed, de-
fensins, cathelicidins, and others are produced as propep-
tides that require some degree of proteolytic processing to
attain full antimicrobial activity (Lehrer and Ganz, 1996).
Our work demonstrates that bacterial infection of epi-
thelial cells results in the generation of a bacteriocidal ac-
tivity against different species of gram negative bacteria
concomitantly with the induction of the expression and ac-
tivation of matrilysin (Fig. 9). Because matrilysin does not
have a direct bacteriocidal effect, we hypothesize that this
enzyme modulates the activity of defense-related mole-
cules. Indeed, we have recently demonstrated that crypt-
dins (enteric a-defensins), a group of small cationic pep-
tides with broad antimicrobial activity (Ouellette et al.,
1994; Ouellette and Selsted, 1996), are processed to their
active forms by matrilysin and that a deficiency in this en-
zyme results in impaired bacteriocidal activity in vivo
(Wilson et al., 1999). We speculate that matrilysin may
play a similar role in other epithelia, thus, contributing to
mechanisms of innate host defense at mucosal surfaces.
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